| abstract |
In postmenopausal women, symptoms or diseases caused by menopausal symptoms, particularly in sensitive warm-blooded animals including humans, are associated with osteoporosis, vaginal atrophy and vaginal dryness, hypogonadism, hypogonadism, skin atrophy, connective tissue disease, urinary incontinence, A new method involving the administration of sex steroid precursors to reduce or treat the likelihood of acquiring physical symptoms of cancer, ovarian cancer, uterine cancer, facial flushing, decreased muscle mass, insulin resistance, fatigue, decreased energy, . (DHEA) to take advantage of the positive androgenic effect in the vaginal lamina and / or vaginal muscle layer without causing unnecessary systemic estrogenic effects to block the risk of breast cancer and ovarian cancer. ≪ RTI ID = 0.0 > Administration and administration. |